The effect of dexamethasone treatment on murine colitis

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 5, 2000, Pages 517-521

  Van Meeteren, M E ^a   Meijssen, M A C ^a   Zijlstra, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Colitis; Corticosteroids; Dexamethasone; Dextran sulphate sodium; Mice

Indexed keywords

DEXAMETHASONE SODIUM PHOSPHATE; DEXTRAN SULFATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0034123602     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750023787     Document Type: Article

References (19)

1. 1. Reynolds PD, Hunter JO. Pharmacotherapy of inflammatory bowel disease. Dig Dis 1993;11:334-42.
2. 2. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694-702.
3. 3. Zijlstra FJ, Garrelds IM, van Dijk APM, Wilson JHP. Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonie tissue. Agents Actions 1992;35:C76-8.
4. 4. Axelsson LG, Landström E, Bylund-Fellenius AC. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther 1998;12:925-34.
5. 5. Elson CO. The basis of current and future therapy for inflammatory bowel disease. Am J Med 1996;100:656-62.
6. 6. Giaffer MH, O'Brien CJ, Holdsworth CD. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine. Aliment Pharmacol Ther 1992;6:51-9.
7. 7. Hanauer SB. Review articles: drug therapy: inflammatory bowel disease. N Engl J Med 1996;334:841-8.
8. 8. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10:81-90.
9. 9. Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis. Gut 1987;28: 1095-9.
10. 10. Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996;31 Suppl 216:149-59.
11. 11. Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436-41.
12. 12. Friend DR, Phillips S, McLeod A, Tozer TN. Relative antiinflammatory effect of oral dexamethasone-beta-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea-pigs. J Pharm Pharmacol 1991;43:353-5.
13. 13. Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J, et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997;107:353-8.
14. 14. Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643-52.
15. 15. Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg 1998;Suppl:90-8.
16. 16. Palmen MJ, Dieleman LA, Soesatyo M, Pena AS, Meuwissen SG, van Rees EP. Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats. Dig Dis Sci 1998;43:2518-25.
17. 17. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238-49.
18. 18. Parry EW. The role of enteric bacteria in the pathogenesis of fatal cycloheximide intolerance in mice pretreated with dexamethasone, promethazine or nordihydroguaiaretic acid. Inflamm Res 1996;45:354-6.
19. 19. Bylund-Fellenius A-C, Axelsson L-G, Midtvedt T. Experimental colitis induced by dextran sulphate in normal and germfree mice. Microb Ecol Health Dis 1994;7:207-15.